✨
AI Summary
- CytoReason co-founder Shai Shen-Orr discusses disease modeling as the next frontier in healthcare AI applications
- The platform bridges the gap between biological data abundance and actionable insights for drug development teams
- CytoReason accelerates pharma and biotech innovation by enabling smarter, faster research decision-making
Guests on This Episode
SS
Shai Shen-Orr
1 podcast appearance